E. Kurschel

548 total citations
15 papers, 435 citations indexed

About

E. Kurschel is a scholar working on Oncology, Rheumatology and Immunology. According to data from OpenAlex, E. Kurschel has authored 15 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 3 papers in Rheumatology and 3 papers in Immunology. Recurrent topics in E. Kurschel's work include Colorectal Cancer Treatments and Studies (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Metastasis and carcinoma case studies (2 papers). E. Kurschel is often cited by papers focused on Colorectal Cancer Treatments and Studies (4 papers), Eosinophilic Disorders and Syndromes (3 papers) and Metastasis and carcinoma case studies (2 papers). E. Kurschel collaborates with scholars based in Germany, United States and Sweden. E. Kurschel's co-authors include R. Osieka, Carl G. Schmidt, Antonius A. Miller, N. Niederle, J. M. Baumann, Thomas Moritz, E. Schlick, C. G. Schmidt, J. Kempeni and Dieter May and has published in prestigious journals such as Nephrology Dialysis Transplantation, Advances in experimental medicine and biology and Journal of Molecular Medicine.

In The Last Decade

E. Kurschel

14 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Kurschel Germany 7 223 115 78 49 41 15 435
Susanne Vejda Austria 11 330 1.5× 90 0.8× 38 0.5× 55 1.1× 56 1.4× 11 477
Janice M. Kraniak United States 11 222 1.0× 104 0.9× 84 1.1× 20 0.4× 40 1.0× 15 497
Ngin Cin Khai Japan 9 192 0.9× 104 0.9× 26 0.3× 65 1.3× 37 0.9× 9 449
Suk-Ran Yoon South Korea 11 270 1.2× 88 0.8× 223 2.9× 42 0.9× 38 0.9× 12 573
Masaharu Aritomi Japan 11 177 0.8× 46 0.4× 98 1.3× 128 2.6× 20 0.5× 13 437
Diederik van Bodegom United States 7 185 0.8× 101 0.9× 57 0.7× 40 0.8× 28 0.7× 10 360
Tomoko Ota Japan 12 163 0.7× 193 1.7× 79 1.0× 16 0.3× 31 0.8× 22 507
Anna-Karin Sjögren Sweden 17 541 2.4× 124 1.1× 124 1.6× 27 0.6× 19 0.5× 26 865
Gabriella Regis Italy 10 235 1.1× 326 2.8× 255 3.3× 48 1.0× 39 1.0× 10 627
K. B. Cooke United Kingdom 11 159 0.7× 58 0.5× 56 0.7× 51 1.0× 32 0.8× 21 419

Countries citing papers authored by E. Kurschel

Since Specialization
Citations

This map shows the geographic impact of E. Kurschel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Kurschel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Kurschel more than expected).

Fields of papers citing papers by E. Kurschel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Kurschel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Kurschel. The network helps show where E. Kurschel may publish in the future.

Co-authorship network of co-authors of E. Kurschel

This figure shows the co-authorship network connecting the top 25 collaborators of E. Kurschel. A scholar is included among the top collaborators of E. Kurschel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Kurschel. E. Kurschel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Niederle, N., E. Kurschel, & C. G. Schmidt. (2008). Biologischer Effekt von rekombiniertem Leukozyten-alpha2-Interferon bei metastasierten kolorektalen Karzinomen. DMW - Deutsche Medizinische Wochenschrift. 109(20). 779–782.
2.
Kurschel, E., et al.. (1991). Investigations on the Subclinical and Clinical Nephrotoxicity of Interferon α-2B in Patients with Myeloproliferative Syndromes. Renal Failure. 13(2-3). 87–93. 32 indexed citations
3.
Kurschel, E., et al.. (1990). Folate Nephropathy Occurring During Cytotoxic Chemotherapy with High-Dose Folinic Acid and 5-Fluorouracil. Renal Failure. 12(2). 93–97. 36 indexed citations
4.
Kurschel, E., et al.. (1990). Investigations on the acute and chronic nephrotoxicity of the new platinum analogue carboplatin. Journal of Cancer Research and Clinical Oncology. 116(2). 203–206. 5 indexed citations
5.
Aulbert, E., Manuel O. Jakob, & E. Kurschel. (1989). Die Anämie bei malignen Tumorerkrankungen. Oncology Research and Treatment. 12(2). 81–89. 2 indexed citations
6.
Moritz, Thomas, N. Niederle, J. M. Baumann, et al.. (1989). Phase I study of recombinant human tumor necrosis factor ? in advanced malignant disease. Cancer Immunology Immunotherapy. 29(2). 144–50. 90 indexed citations
7.
Aulbert, E., et al.. (1989). [Anemia in malignant tumor diseases. VI. Secondary siderosis caused by the shift of iron, unused for hemoglobin synthesis, into iron stores].. PubMed. 84(9). 421–8. 1 indexed citations
8.
Becher, R., et al.. (1989). Ifosfamide, methotrexate, and 5-fluorouracil in advanced pretreated breast cancer.. PubMed. 16(1 Suppl 3). 56–9. 13 indexed citations
9.
Becher, R., E. Kurschel, O. Kloke, et al.. (1988). 5-Fluorouracil and 5-Formyltetrahydrofolate in Advanced Malignancies. Advances in experimental medicine and biology. 244. 225–232. 2 indexed citations
10.
Doberauer, C., et al.. (1987). Zur Behandlung des metastasierten Karzinoids von Ileum und Caecum mit rekombinantem Interferon alpha-2b. Oncology Research and Treatment. 10(6). 340–344. 10 indexed citations
11.
Miller, Antonius A., E. Kurschel, R. Osieka, & Carl G. Schmidt. (1987). Clinical pharmacology of sodium butyrate in patients with acute leukemia. European Journal of Cancer and Clinical Oncology. 23(9). 1283–1287. 215 indexed citations
13.
Kurschel, E., et al.. (1987). Urinary Enzyme Excretion During Treatment of Malignancies With Human Recombinant Alpha-2 Interferon. Nephrology Dialysis Transplantation. 2(6). 515–519. 1 indexed citations
14.
Clark, Peter, M L Slevin, R H Reznek, et al.. (1987). Two randomised phase II trials of intermittent intravenous versus subcutaneous alpha-2 interferon alone (Trial 1) and in combination with 5-fluorouracil (Trial 2) in advanced colorectal cancer. International Journal of Colorectal Disease. 2(1). 26–29. 20 indexed citations
15.
Höffken, K., B. Miller, P Fischer, et al.. (1986). Buserelin in treatment of premenopausal advanced breast cancer. European Journal of Cancer and Clinical Oncology. 22(6). 746–746. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026